Selecta Biosciences

Selecta Biosciences

Selecta Biosciences

Selecta Biosciences, a biopharmaceutical company, develops nanoparticle immunomodulatory drugs for the treatment and prevention of diseases.
Founded
2008
Raised
$87.7M
Follow us
Alexa global traffic share
Latest funding Show all
$20,000,000
Private equity - 2014
$4,450,000
Venture capital - 2014
Team Size
10+
Employees
Xconomy

Retooled Selecta Bio Takes Crossover Cash to IPO Queue

Science Health Stock markets